GlobeImmune raises $17.25 million in IPO
Last Updated: 17:52 July 8, 2014
The Louisville-based biopharmaceutical company sold 1.725 million shares of its common stock for $10 each, including 225,000 shares sold pursuant to the exercise of the underwriter's overallotment option.
The gross proceeds amount is prior to the deduction of underwriting discounts and commissions and other offering expenses.
GlobeImmune shares began trading July 2. The share price closed at $12.89 Tuesday, up 12 percent from the previous day's close.
More breaking news...
RGS to discuss results Aug. 13
Dynamic Materials 2Q sales slide 7 percent
RGS chief executive
Construction jobs rising in region
DMC released its earnings